Clinical Trial

School-Based Sensory Processing and Daily Living Skills-Focused Occupational Therapy Program

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to develop and evaluate a school-based occupational therapy program focused on sensory processing and activities of daily living for children with Autism Spectrum Disorder and Intellectual Disability. Sensory processing difficulties often affect school participation, behavior regulation, and independence in daily tasks. Although occupational therapy interventions have shown benefits in clinical settings, evidence for their use in schools is limited. The trial will take place at Vali Ayhan Çevik Special Education School and will enroll students aged 6 to 14 years. Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive weekly 50-minute occupational therapy sessions for 10 to 12 weeks, including sensory preparation, task-oriented practice, and strategies to support everyday skills. The control group will receive family education, a written home program, and routine school observation. Outcomes will be assessed at baseline, after the intervention, and at 4 to 6-week follow-up. The main outcome is change in Goal Attainment Scaling scores, which reflect progress toward individualized goals. Additional measures include functional ability, sensory processing, and demographic and clinical information. The study will also monitor feasibility and how closely the program is delivered as planned. This research is expected to provide evidence on the feasibility and effects of a standardized occupational therapy program in a school setting and to support the use of similar approaches in educational contexts.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-01-01 -> 2027-03-01 2026-04-10
minor Completion moved earlier: 2028-01-01 -> 2027-03-01 2026-04-10
Trial Details
NCT Number NCT07326267
Lead Sponsor Çankırı Karatekin University
Conditions Intellectual Disability, Variable, Autism Spectrum Disorder (ASD)
Enrollment 40 participants
Start Date 2026-05-04
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-09